TY - JOUR
T1 - Cardiovascular risk factors and comorbidities in people living with HIV
T2 - A cross-sectional multicenter study from Colombia comorbidities in a Colombian PLWHIV population
AU - Valderrama-Beltrán, Sandra
AU - Martínez-Vernaza, Samuel
AU - Figueredo, María
AU - Martínez, Ernesto
AU - Blair, Kevin J
AU - Cuervo-Rojas, Juliana
AU - Arévalo, Leonardo
AU - De La Hoz, Alejandro
AU - Quiroga, Camilo
AU - Mueses, Héctor
AU - Sussmann, Otto
AU - Mantilla, Mónica
AU - Ramírez, Christian
AU - Gonzalez, Claudia
AU - Montero-Riascos, Leonardo
AU - Botero, Monica
AU - Alzate-Ángel, Juan
AU - García-Garzón, Martha
AU - Franco, Julieta
AU - Lenis, William
AU - Galindo-Orrego, Ximena
AU - Stand, Javier
AU - Fonseca, Norberto
AU - Alzamora, Diana
AU - Ramos, Olga
AU - Tobon, Wilmar
AU - Ruiz, Jaime
AU - León, Sebastián
AU - Rojas-Rojas, Monica
AU - Urrego-Reyes, Juan
AU - Beltrán-Rodríguez, Claudia
AU - Rosselli, Diego
AU - Rodriguez-Lugo, Diego-Andres
AU - Villamil-Castañeda, Lina Paola
AU - Álvarez-Moreno, Carlos
N1 - Publisher Copyright:
© The Author(s) 2022.
PY - 2022/6
Y1 - 2022/6
N2 - INTRODUCTION: HIV is an independent risk factor for cardiovascular diseases (CVD). There is insufficient information regarding comorbidities and cardiovascular risk factors in the Colombian HIV population. The aim of this study is to describe the prevalence of cardiovascular risk factors and comorbidities in patients from the HIV Colombian Group VIHCOL.METHODS: This is a multicenter, cross-sectional study conducted in the VIHCOL network in Colombia. Patients 18 years or older who had at least 6 months of follow-up were included. A stratified random sampling was performed to estimate the adjusted prevalence of cardiovascular risk factors and comorbidities.RESULTS: A total of 1616 patients were included. 83.2% were men, and the median age was 34 years. The adjusted prevalence for dyslipidemia, active tobacco use, hypothyroidism, and arterial hypertension was 51.2% (99% CI: 48.0%-54.4%), 7.6% (99% CI: 5.9%-9.3%), 7.4% (99% CI: 5.7%-9.1%), and 6.3% (99% CI: 4.8%-7.9%), respectively.CONCLUSIONS: In this Colombian HIV cohort, there is a high prevalence of modifiable CVD risk factors such as dyslipidemia and active smoking. Non-pharmacological and pharmacological measures for the prevention and management of these risk factors should be reinforced.
AB - INTRODUCTION: HIV is an independent risk factor for cardiovascular diseases (CVD). There is insufficient information regarding comorbidities and cardiovascular risk factors in the Colombian HIV population. The aim of this study is to describe the prevalence of cardiovascular risk factors and comorbidities in patients from the HIV Colombian Group VIHCOL.METHODS: This is a multicenter, cross-sectional study conducted in the VIHCOL network in Colombia. Patients 18 years or older who had at least 6 months of follow-up were included. A stratified random sampling was performed to estimate the adjusted prevalence of cardiovascular risk factors and comorbidities.RESULTS: A total of 1616 patients were included. 83.2% were men, and the median age was 34 years. The adjusted prevalence for dyslipidemia, active tobacco use, hypothyroidism, and arterial hypertension was 51.2% (99% CI: 48.0%-54.4%), 7.6% (99% CI: 5.9%-9.3%), 7.4% (99% CI: 5.7%-9.1%), and 6.3% (99% CI: 4.8%-7.9%), respectively.CONCLUSIONS: In this Colombian HIV cohort, there is a high prevalence of modifiable CVD risk factors such as dyslipidemia and active smoking. Non-pharmacological and pharmacological measures for the prevention and management of these risk factors should be reinforced.
KW - HIV
KW - South America
KW - epidemiology
UR - http://www.scopus.com/inward/record.url?scp=85131654640&partnerID=8YFLogxK
U2 - 10.1177/09564624221089456
DO - 10.1177/09564624221089456
M3 - Article
C2 - 35502981
AN - SCOPUS:85131654640
SN - 0956-4624
VL - 33
SP - 641
EP - 651
JO - International Journal of STD and AIDS
JF - International Journal of STD and AIDS
IS - 7
ER -
